Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Pruitt

Showing results (61-70 of 84) with videos related to

Pageof 9
Sort By:
Journal of the American College of Surgeons|August 25, 2004
In-transit melanoma: the role of alkylating-agent resistance in regional therapyElizabeth G Grubbs, Omar Abdel-Wahab, Tsung-Yen Cheng, et al.
Clinical Pharmacology and Therapeutics|December 6, 2020
Experimental Medicine Study to Measure Immune Checkpoint Receptors PD-1 and GITR Turnover Rates In Vivo in HumansMichael E Lassman, Derek L Chappell, Thomas McAvoy, et al.
Molecular Cancer Therapeutics|May 8, 2007
Defining regional infusion treatment strategies for extremity melanoma: comparative analysis of melphalan and temozolomide as regional chemotherapeutic agentsYasunori Yoshimoto, Christina K Augustine, Jin S Yoo, et al.
Transplantation Proceedings|February 1, 1997
Overcoming rejection in pig-to-primate cardiac xenotransplantationE A Davis, F Jakobs, S K Pruitt, et al.
Journal of the American College of Surgeons|April 16, 2011
Current trends in regional therapy for melanoma: lessons learned from 225 regional chemotherapy treatments between 1995 and 2010 at a single institutionAmanda K Raymond, Georgia M Beasley, Gloria Broadwater, et al.
Annals of Surgical Oncology|June 6, 2008
Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusionGeorgia M Beasley, Rebecca P Petersen, Jin Yoo, et al.
Cellular Immunology|November 12, 2003
Induction of anti-melanoma CTL response using DC transfected with mutated mRNA encoding full-length Melan-A/MART-1 antigen with an A27L amino acid substitutionZeinab Abdel-Wahab, Matthew F Kalady, Sirisha Emani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2001
Induction of polyclonal prostate cancer-specific CTL using dendritic cells transfected with amplified tumor RNAA Heiser, M A Maurice, D R Yancey, et al.
Annals of Surgical Oncology|February 26, 2010
Inhibition of poly(ADP-ribose) polymerase enhances the effect of chemotherapy in an animal model of regional therapy for the treatment of advanced extremity malignant melanomaHiroaki Toshimitsu, Yasunori Yoshimoto, Christina K Augustine, et al.
Scientific Reports|April 24, 2014
High-throughput identification and dendritic cell-based functional validation of MHC class I-restricted Mycobacterium tuberculosis epitopesSmita K Nair, Georgia D Tomaras, Ana Paula Sales, et al.
Pageof 9

Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
Journal of the American College of Surgeons|August 25, 2004
In-transit melanoma: the role of alkylating-agent resistance in regional therapyElizabeth G Grubbs, Omar Abdel-Wahab, Tsung-Yen Cheng, et al.
Clinical Pharmacology and Therapeutics|December 6, 2020
Experimental Medicine Study to Measure Immune Checkpoint Receptors PD-1 and GITR Turnover Rates In Vivo in HumansMichael E Lassman, Derek L Chappell, Thomas McAvoy, et al.
Molecular Cancer Therapeutics|May 8, 2007
Defining regional infusion treatment strategies for extremity melanoma: comparative analysis of melphalan and temozolomide as regional chemotherapeutic agentsYasunori Yoshimoto, Christina K Augustine, Jin S Yoo, et al.
Transplantation Proceedings|February 1, 1997
Overcoming rejection in pig-to-primate cardiac xenotransplantationE A Davis, F Jakobs, S K Pruitt, et al.
Journal of the American College of Surgeons|April 16, 2011
Current trends in regional therapy for melanoma: lessons learned from 225 regional chemotherapy treatments between 1995 and 2010 at a single institutionAmanda K Raymond, Georgia M Beasley, Gloria Broadwater, et al.
Annals of Surgical Oncology|June 6, 2008
Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusionGeorgia M Beasley, Rebecca P Petersen, Jin Yoo, et al.
Cellular Immunology|November 12, 2003
Induction of anti-melanoma CTL response using DC transfected with mutated mRNA encoding full-length Melan-A/MART-1 antigen with an A27L amino acid substitutionZeinab Abdel-Wahab, Matthew F Kalady, Sirisha Emani, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 24, 2001
Induction of polyclonal prostate cancer-specific CTL using dendritic cells transfected with amplified tumor RNAA Heiser, M A Maurice, D R Yancey, et al.
Annals of Surgical Oncology|February 26, 2010
Inhibition of poly(ADP-ribose) polymerase enhances the effect of chemotherapy in an animal model of regional therapy for the treatment of advanced extremity malignant melanomaHiroaki Toshimitsu, Yasunori Yoshimoto, Christina K Augustine, et al.
Scientific Reports|April 24, 2014
High-throughput identification and dendritic cell-based functional validation of MHC class I-restricted Mycobacterium tuberculosis epitopesSmita K Nair, Georgia D Tomaras, Ana Paula Sales, et al.
Pageof 9